Centers

Collaborative Drug Discovery, Inc.

Edinburgh Drug Discovery

EU-OPENSCREEN

Chemical registration system

Activity & Registration - Web application within CDD Vault for chemical registration, assay data management, and SAR analysis.

Scientific visualization
Visualization - Web application within CDD Vault allowing...


Read more

Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of...

Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

Partnerships

Events

Jobs

TB Drug Accelerator

  • The TB Drug Accelerator Programme aims to speed up the discovery and development of novel compounds against tuberculosis (TB).

 
View all

Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space

Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. Scientists from both groups will be...

 
View all

UCB Partners with Oxford University

UCB has entered into a research and development partnership with Oxford University in Neurology and Immunology areas. UCB will provide 3.6 million pounds to Oxford scientists over a period of three year to conduct research.

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All